Cannell Capital LLC Eton Pharmaceuticals, Inc. Transaction History
Cannell Capital LLC
- $301 Million
- Q2 2025
A detailed history of Cannell Capital LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Cannell Capital LLC holds 388,175 shares of ETON stock, worth $6.72 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
388,175
Previous 691,367
43.85%
Holding current value
$6.72 Million
Previous $8.97 Million
38.36%
% of portfolio
1.84%
Previous 3.17%
Shares
3 transactions
Others Institutions Holding ETON
# of Institutions
85Shares Held
15MCall Options Held
242KPut Options Held
11.8K-
Opaleye Management Inc. Boston, MA2.86MShares$49.5 Million9.75% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$35.2 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$22.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$20.4 Million0.73% of portfolio
-
Geode Capital Management, LLC Boston, MA593KShares$10.3 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $438M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...